SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,112,050. The last known price of Bitcoin is 63,437.21016941 USD and is down -7.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $45,086,253,428.50 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below short-term support levels dominate the discussion, with traders worried about further declines and possible cascading liquidations. The community is split between bearish calls for more downside and investors viewing the drop as capitulation or a buying opportunity; proposed causes such as institutional selling and broader market weakness remain speculation.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a broad crypto selloff, with Bitcoin weakness and forced liquidations adding to pressure. Traders are divided between treating the drop as capitulation and buying the dip, and expecting further losses; some also speculate that macro uncertainty and competition for capital are weighing on crypto.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp selloff is weighing on Strategy shares, with traders treating MSTR as a leveraged Bitcoin proxy and debating whether further crypto losses could pressure its holdings and financing strategy. The community is also focused on the announced MSCI index removal and potential passive selling, while some traders view the decline as a buying opportunity.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a steep decline alongside broader crypto weakness, with traders pointing to fresh multi-year lows and questioning whether buyers will step in. The discussion is largely bearish, though some see the selloff as a buying opportunity and expect a rebound.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is drawing attention amid a sharp crypto-wide selloff, with traders pointing to Bitcoin weakness and leveraged liquidations as pressure on the token. The community is split between expecting further declines and viewing the drop as a buying opportunity, with many expressing concern that XRP has fallen below the $1 level.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,554,569.48929238 with 591,573,607.37721086 in circulation. The last known price of Solana is 69.50906472 USD and is down -10.60 over the last 24 hours. It is currently trading on 1189 active market(s) with $4,775,978,662.51 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is drawing attention amid a sharp crypto-wide selloff, with traders focused on its steep decline and whether the weakness signals further downside. Bearish calls about capitulation and lower support levels compete with dip-buying and staking advocates who view the drop as an accumulation opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Norwalk, CT.

BitMine Immersion Technologies Inc

Ethereum and broader crypto weakness are weighing on BMNR, whose large ETH treasury makes its shares sensitive to the tokens decline. Traders are split between expecting a rebound and criticizing the stocks losses, Tom Lees bullish calls, and the pace of buybacks.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,407,563,191.01116 in circulation. The last known price of Stellar is 0.13466341 USD and is down -7.69 over the last 24 hours. It is currently trading on 849 active market(s) with $286,159,144.84 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention amid a steep selloff alongside broader crypto weakness, with traders debating whether the decline will continue or offer a buying opportunity. Some holders point to Stellars tokenization and institutional-adoption prospects, including DTCC-related developments, but others question whether those developments will translate into demand for XLM.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,139,454.06818907 in circulation. The last known price of Hedera is 0.05610846 USD and is down -8.30 over the last 24 hours. It is currently trading on 469 active market(s) with $93,154,645.45 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBAR is drawing attention amid a sharp selloff and broader weakness across crypto, with traders debating whether the drop is a buying opportunity or evidence of a prolonged downtrend. Some also blame dilution and weak demand, while long-term holders continue to accumulate and others question the tokens value and prospects.

Hyperliquid (HYPE) is a cryptocurrency and operates on the Hyperliquid platform. Hyperliquid has a current supply of 949,785,693.40635688 with 252,693,588.19239903 in circulation. The last known price of Hyperliquid is 63.91203856 USD and is down -10.91 over the last 24 hours. It is currently trading on 360 active market(s) with $1,650,066,535.61 traded over the last 24 hours. More information can be found at https://hyperliquid.xyz/.

Hype

A sharp crypto pullback and HYPEs volatile decline are driving discussion, with traders debating whether the weakness signals further downside or a buying opportunity. Bulls point to Hyperliquids fee-driven buybacks and growing institutional interest, while bears highlight relative weakness and selling pressure.

statis crypto Watchlist

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge

Key PointsFCPM III Services B.V. initiated a new position in Damora Therapeutics, adding 2,441,000 shares last quarter; the estimated trade size was $65.63 million (quarterly average pricing...

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Gap Down - Here's Why

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Gap Down - Should You Sell...

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Sees Large Increase in Short Interest

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totaling...

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Upgraded at Royal Bank Of Canada

Royal Bank Of Canada raised shares of Damora Therapeutics, Inc. Common Stock to a "moderate buy" rating in a report on Thursday...

Royal Bank Of Canada Begins Coverage on Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)

Royal Bank Of Canada started coverage on Damora Therapeutics, Inc. Common Stock in a report on Friday. They set an "outperform" rating and a $40.00 price objective for the company...

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the...

What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?

Does Galecto, Inc. (DMRA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Short Interest Update

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 827,221 shares...

How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%

The average of price targets set by Wall Street analysts indicates a potential upside of 73.1% in DAMORA THERAPEU (DMRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Up 3.9%  - Here's Why

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Stock Price Up 3.9% - What's Next...

Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.

Damora Therapeutics Inc.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	-$0.55	--	--	N/A
Q3 '26	-$0.48	-$0.40	17.10%	BEAT
Q2 '26	-$0.41	--	--	N/A
Q1 '26	-$0.39	-$0.62	-59.89%	MISSED
Q4 '25	$0.90	$2.90	221.46%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

DMRA Earnings

Latest Earnings Results: Q3 '26

Historical Earnings